Popular
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
CME/CEReady, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Carolyn Lam, MD, PhD
Stephen J. Greene, MD
INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
NephrologyINFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
Peter Rossing, MD, DMSc
Hypopigmentation in Atopic Dermatitis Patients with Skin of Color
Dermatology Hub: Neuroimmune NetworkHypopigmentation in Atopic Dermatitis Patients with Skin of Color
Cheri Frey, MD
Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
Stephen Brunton, MD, FAAFP, CDCES
James R. Gavin III, MD, PhD
Davida F. Kruger, MSN, APN-BC, BC-ADM
Eden Miller, DO, D-ACD, D-ABOM
Navigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Heart MattersNavigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Brian P. McDonough, MD, FAAFP
Ahmet Kilic, MD FACS
Programs
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Katherine Tuttle, MD
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Innovations In MedicineCentanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Jennifer Caudle, DO, FACOFP
Greg Mattingly, MD
Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
CME/CEHypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
Dolores Shoback, MD
Michael T. Collins, MD
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
CardiologyAPOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Clinical Practice
Real-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes
Diabetes and EndocrinologyReal-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes
Csaba P. Kovesdy, MD
Navigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Heart MattersNavigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Brian P. McDonough, MD, FAAFP
Ahmet Kilic, MD FACS
Helping Patients Stay on Track With Collaborative LDL-C Care
Medical Industry FeatureHelping Patients Stay on Track With Collaborative LDL-C Care
Barry D. Bertolet MD, FACC
Todd Sandroni PharmD
Navigating the Limitations of Current BD Therapies
MinuteCE®Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
MinuteCE®Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
Komal Jhaveri, MD, FACP
Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CEOral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
Doctors Lounge
Brian P. McDonough, MD, FAAFP
Michael Moor, MD, PhD
The Changing Landscape of CRC Screening and Prevention
On the Frontlines of Colorectal CancerThe Changing Landscape of CRC Screening and Prevention
Ryan Quigley
Samuel Muench, MD
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
Bruno Batinica, MD
Optimizing Medical Affairs Approaches with CME Best Practices
MAPSChatsOptimizing Medical Affairs Approaches with CME Best Practices
Matt Birnholz, MD
Karen Roy, MSc
CME
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
- MinuteCE®
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
PSVT Management: Suboptimal Care Is Too Frequent
MinuteCE®PSVT Management: Suboptimal Care Is Too Frequent
Brian P. Rose, PA-C, MPH, AACC
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
MinuteCE®Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
MinuteCE®The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
MinuteCE®Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
Saad Z. Usmani, MD, MBA
Industry Feature
Single-Port Robotics Improves Outcomes for Thoracic Surgery
Medical Industry FeatureSingle-Port Robotics Improves Outcomes for Thoracic Surgery
Benjamin Lee, M.D.
Jeffrey Port, M.D.
Jonathan Villena-Vargas, M.D.
Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment
Jennifer Caudle, DO, FACOFP
David Lynch, MD
Laura Bleekrode, MD
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD
Innovations In MedicineCentanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD
Charles Turck, PharmD, BCPS, BCCCP
Joel L. Young, MD
What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Jennifer Caudle, DO, FACOFP
Syma Iqbal, MD
Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Innovations In MedicineNavigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Charles Turck, PharmD, BCPS, BCCCP
Andrew Freeman, MD, FACC, FACP
The Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Medical Industry FeatureThe Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC